Healthcare Executive Passes Out at Oval Office During Weight Loss Drug Announcement
WASHINGTON (TNND) — Novo Nordisk executive Gordon Findlay fainted Thursday in the Oval Office during an event about new weight loss drugs. The press conference was briefly paused as President Donald Trump and Dr. Mehmet Oz turned their attention to assist him.
According to White House Press Secretary Karoline Leavitt, the incident happened during the “Most Favored Nations” Oval Office announcement. She confirmed that Findlay was treated swiftly by the White House Medical Unit and is expected to recover fully.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," Leavitt said. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly."
The event focused on a new agreement between the U.S. government, Eli Lilly, and Novo Nordisk. Under the deal, certain obesity medications would be available to Americans for approximately $150 per month.
The moment of Findlay’s collapse occurred while Eli Lilly CEO David Ricks was speaking. Reporters were asked to leave the room briefly, and Dr. Kennedy sought medical aid. The briefing resumed by 1:29 p.m., according to Deputy Press Secretary Kush Desai.
Author’s Summary
Novo Nordisk’s Gordon Findlay fainted during an Oval Office announcement led by President Trump about affordable weight loss drug pricing, halting the event briefly before it resumed.